103 related articles for article (PubMed ID: 2543485)
21. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.
Diamond DC; Sleckman BP; Gregory T; Lasky LA; Greenstein JL; Burakoff SJ
J Immunol; 1988 Dec; 141(11):3715-7. PubMed ID: 2846691
[TBL] [Abstract][Full Text] [Related]
22. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4.
Bedinger P; Moriarty A; von Borstel RC; Donovan NJ; Steimer KS; Littman DR
Nature; 1988 Jul; 334(6178):162-5. PubMed ID: 3260353
[TBL] [Abstract][Full Text] [Related]
23. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
24. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein.
Chaudhary VK; Mizukami T; Fuerst TR; FitzGerald DJ; Moss B; Pastan I; Berger EA
Nature; 1988 Sep; 335(6188):369-72. PubMed ID: 2843774
[TBL] [Abstract][Full Text] [Related]
25. Trypsin-resistant gp120 receptors are upregulated on short-term cultured human epidermal Langerhans cells.
Dezutter-Dambuyant C; Schmitt DA; Dusserre N; Hanau D; Kolbe HV; Kieny MP; Gazzolo L; Macé K; Pasquali JL; Olivier R
Res Virol; 1991; 142(2-3):129-38. PubMed ID: 1896637
[TBL] [Abstract][Full Text] [Related]
26. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.
Rowell JF; Stanhope PE; Siliciano RF
J Immunol; 1995 Jul; 155(1):473-88. PubMed ID: 7602119
[TBL] [Abstract][Full Text] [Related]
27. Designing CD4 immunoadhesins for AIDS therapy.
Capon DJ; Chamow SM; Mordenti J; Marsters SA; Gregory T; Mitsuya H; Byrn RA; Lucas C; Wurm FM; Groopman JE
Nature; 1989 Feb; 337(6207):525-31. PubMed ID: 2536900
[TBL] [Abstract][Full Text] [Related]
28. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
Wu L; Gerard NP; Wyatt R; Choe H; Parolin C; Ruffing N; Borsetti A; Cardoso AA; Desjardin E; Newman W; Gerard C; Sodroski J
Nature; 1996 Nov; 384(6605):179-83. PubMed ID: 8906795
[TBL] [Abstract][Full Text] [Related]
29. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
Willey RL; Bonifacino JS; Potts BJ; Martin MA; Klausner RD
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9580-4. PubMed ID: 2849111
[TBL] [Abstract][Full Text] [Related]
30. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.
Chirmule N; Kalyanaraman VS; Lederman S; Oyaizu N; Yagura H; Yellin MJ; Chess L; Pahwa S
J Immunol; 1993 Mar; 150(6):2478-86. PubMed ID: 8450224
[TBL] [Abstract][Full Text] [Related]
31. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding.
Clayton LK; Hussey RE; Steinbrich R; Ramachandran H; Husain Y; Reinherz EL
Nature; 1988 Sep; 335(6188):363-6. PubMed ID: 2843773
[TBL] [Abstract][Full Text] [Related]
32. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
33. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia.
Hussain LA; Lehner T
Immunology; 1995 Jul; 85(3):475-84. PubMed ID: 7558138
[TBL] [Abstract][Full Text] [Related]
34. T cells can present antigens such as HIV gp120 targeted to their own surface molecules.
Lanzavecchia A; Roosnek E; Gregory T; Berman P; Abrignani S
Nature; 1988 Aug; 334(6182):530-2. PubMed ID: 2841610
[TBL] [Abstract][Full Text] [Related]
35. HIV infection: the cellular picture.
Weber JN; Weiss RA
Sci Am; 1988 Oct; 259(4):100-9. PubMed ID: 2854299
[No Abstract] [Full Text] [Related]
36. A rapid solution immunoassay to quantify binding of the human immunodeficiency virus envelope glycoprotein to soluble CD4.
McQuade TJ; Pitts TW; Tarpley WG
Biochem Biophys Res Commun; 1989 Aug; 163(1):172-6. PubMed ID: 2549987
[TBL] [Abstract][Full Text] [Related]
37. Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding.
Cordonnier A; Rivière Y; Montagnier L; Emerman M
J Virol; 1989 Oct; 63(10):4464-8. PubMed ID: 2550679
[TBL] [Abstract][Full Text] [Related]
38. Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120.
Lucey DR; Dorsky DI; Nicholson-Weller A; Weller PF
J Exp Med; 1989 Jan; 169(1):327-32. PubMed ID: 2783333
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to CD4 in individuals infected with human immunodeficiency virus type 1.
Kowalski M; Ardman B; Basiripour L; Lu YC; Blohm D; Haseltine W; Sodroski J
Proc Natl Acad Sci U S A; 1989 May; 86(9):3346-50. PubMed ID: 2541442
[TBL] [Abstract][Full Text] [Related]
40. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.
Matthews TJ; Weinhold KJ; Lyerly HK; Langlois AJ; Wigzell H; Bolognesi DP
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5424-8. PubMed ID: 3037551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
